Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation

David A Katz1,2, Daniel Peck1,2, Adam M Lubert1,2

  • 1Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH.

Insights

Hepatic steatosis, or fatty liver, affects 10.5% of Fontan circulation patients. Risk factors like obesity and dyslipidemia are similar to the general population, not Fontan hemodynamics.

Area of Science:

  • Cardiology
  • Hepatology
  • Radiology

Background:

  • Nonalcoholic fatty liver disease is a primary cause of chronic liver disease.
  • The relationship between hepatic steatosis and liver disease post-Fontan procedure is unclear.
  • This study investigates hepatic steatosis in Fontan circulation patients.

Purpose of the Study:

  • To determine the prevalence of hepatic steatosis in patients with Fontan circulation.
  • To identify associations between hepatic steatosis and patient characteristics.
  • To explore the link between hepatic steatosis and Fontan hemodynamics.

Main Methods:

  • Retrospective single-center study of 95 Fontan circulation patients.
  • Liver magnetic resonance imaging (MRI) used between 2012 and 2019.
  • Proton density fat fraction imaging determined liver fat percentage; hepatic steatosis defined as ≥5% liver fat.

Main Results:

  • Hepatic steatosis was present in 10.5% of the cohort.
  • Steatosis associated with higher BMI, obesity, lower HDL cholesterol, and increased subcutaneous fat.
  • No association found between hepatic steatosis and cardiovascular imaging or hemodynamic variables.

Conclusions:

  • Obesity and dyslipidemia are key risk factors for hepatic steatosis in Fontan patients.
  • These risk factors mirror those observed in the general population.
  • Fontan circulation hemodynamics do not appear to be associated with hepatic steatosis.